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Introduction
The functional organization of the Golgi complex is mediated 
by a wide array of proteins that interact with specific lipid com-
ponents to facilitate membrane bending for vesicle formation 
and tubule fission (Bard and Malhotra, 2006; De Matteis and 
Luini, 2008; Jackson, 2009). Phosphoinositides serve as land-
marks for the recruitment of proteins that regulate diverse traf-
ficking events (Gallop and McMahon, 2005; Bashkirov et al., 
2008; Frost et al., 2009). Lysophospholipids (LPLs), phospha-
tidic acid (PA), and diacylglycerol (DAG) have intrinsic curva-
ture, which may aid in vesicle or tubule formation by altering 
membrane morphology and acting as a scaffold for downstream 
factors (Kooijman et al., 2003; van Meer and Sprong, 2004). 
Phospholipase C (PLC) and phospholipase D (PLD) may pro-
duce DAG or PA for Golgi membrane fission (Bard and Malhotra, 
2006; Fernandez-Ulibarri et al., 2007; Yang et al., 2008; Asp   
et al., 2009). Additionally, phospholipase A2 (PLA2) activity, 
which generates LPLs, appears to be involved in endocytic re-
cycling, Golgi retrograde trafficking, and Golgi cisternal struc-
ture by altering membrane tubule formation (de Figueiredo   
et al., 1998; Brown et al., 2003).
Pharmacological  studies  have  suggested  that  LPL  acyl-
transferases (LPATs) play a role in membrane trafficking by cata-
lyzing the transfer of a fatty acid from an acyl-CoA donor to 
LPLs to generate PLs. The drug CI-976, originally identified as a 
weak cholesterol acyltransferase inhibitor, also inhibits a tightly 
associated Golgi membrane LPAT (Chambers and Brown, 2004), 
with a consequent stimulation of Golgi membrane tubules and 
retrograde trafficking (Drecktrah et al., 2003). CI-976 also inhib-
its COPI (Yang et al., 2005) and COPII vesicle formation (Brown 
et al., 2008) and endocytic recycling (Chambers et al., 2005), 
suggesting the role of multiple LPATs in membrane trafficking.
A family of nine transmembrane acyltransferases, vari-
ously named LPAAT– and AGPAT 1–9 (1-acylglycerol-3-
phosphate-O-acyltransferase) (Lewin et al., 1999; Leung, 2001), 
but more recently LPAAT 1–9 (Shindou and Shimizu, 2009), 
has been identified. Lysophosphatidic acid (LPA) is the pre-
ferred  acceptor  for  LPAAT  enzymes  including  ER-localized 
LPAAT1 and 2, which are involved in de novo PL metabolism; 
however, little is known about the activity, localization, or func-
tion  of  LPAAT3–9  (Shindou  and  Shimizu,  2009).  Recently, 
mouse LPAAT3 was shown to be widely expressed (Lu et al., 
2005), but with an age-dependent elevation of levels in testis 
(Yuki et al., 2009).
Here, we show that LPAAT3 (LPAAT-/AGPAT3) is di-
rectly involved in regulating Golgi membrane trafficking events. 
LPAAT3 prefers LPA as a substrate, but surprisingly the protein   
itself is located in both the ER and Golgi complex. Overexpression 
  R
ecent studies have suggested that the functional   
organization of the Golgi complex is dependent on 
phospholipid remodeling enzymes. Here, we report 
the identification of an integral membrane lysophospha-
tidic acid–specific acyltransferase, LPAAT3, which regu-
lates Golgi membrane tubule formation, trafficking, and 
structure by altering phospholipids and lysophospholipids. 
Overexpression of LPAAT3 significantly inhibited the for-
mation of Golgi membrane tubules in vivo and in vitro. 
Anterograde  and  retrograde  protein  trafficking  was 
slower in cells overexpressing LPAAT3 and accelerated in 
cells with reduced expression (by siRNA). Golgi morphol-
ogy was also dependent on LPAAT3 because its knock-
down  caused  the  Golgi  to  become  fragmented.  These 
data are the first to show a direct role for a specific phos-
pholipid acyltransferase in regulating membrane traffick-
ing and organelle structure.
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can increase the amount of PA in Golgi membranes. These   
results are consistent with reports that other members of this 
family also exhibit LPA acyltransferase activity (Shindou and 
Shimizu, 2009). In addition, mouse LPAAT3 was recently 
shown to have highest activity with LPA, and weaker amounts 
with lysophosphatidylinositol (Yuki et al., 2009), which was 
not tested here.
of LPAAT3 increases Golgi levels of PA and inhibits membrane 
tubule formation and trafficking both in vivo and in vitro. Knock-
down of LPAAT3 caused changes in Golgi morphology as well as 
accelerated trafficking. We conclude that by regulating PA levels, 
LPAAT3 contributes to Golgi structure and trafficking dynamics.
Results and discussion
LPAAT3 is an ER and Golgi-localized 
transmembrane protein
Annotated in the human genome are nine predicated LPAAT   
enzymes, all containing multiple putative transmembrane domains 
and two consensus sequences with similar amino acids that lie 
within a PLsC, or acyltransferase domain (Fig. 1 a). These con-
served regions are likely involved in acid-base sn-2 addition of a 
fatty acid from acyl-CoA to an LPL acceptor, as well as substrate 
binding and specificity (Shindou and Shimizu, 2009).
To identify an LPAAT that might be involved in Golgi 
structure and function, we expressed GFP-tagged versions of four 
uncharacterized LPAATs in HeLa cells to see if any were located 
in the Golgi complex. One of these, LPAAT3, localized in a   
diffuse-ER and juxtanuclear Golgi-like pattern and was therefore 
chosen for further study (Fig. 1). Both expressed LPAAT3-GFP 
(or DsRed) and endogenous LPAAT3 detected by immunofluores-
cence, colocalized with resident cis, medial, and trans-Golgi 
and ER proteins (Fig. 1, b and c; Fig. S1, a–d). HeLa cells and 
Clone 9 rat hepatocytes stably expressing LPAAT3-GFP were 
also generated and displayed Golgi localization (Fig. S1 e). 
The other LPATs we examined were mostly ER-like (LPAAT4 
and 6) or mitochondrial (LPAAT5) (Fig. S2).
LPAAT3 is a lysophosphatidic acid 
acyltransferase
To determine the enzymatic activity of LPAAT3, post-nuclear 
supernatants from cells overexpressing LPAAT3 were incubated 
with 
14C-palmitoyl Co-A and various LPL species to assay for 
the production of radiolabeled PL products. Post-nuclear super-
natants from cells overexpressing LPAAT3 had elevated levels 
of LPA acyltransferase (LPAAT) activity compared with control 
supernatants (Fig. 1 d). Other exogenously added LPLs were 
tested, but there was no significant change in the production of 
the corresponding PL species. This increase in LPAAT activity 
was observed in cells stably or transiently transfected with wild-
type LPAAT3 (LPAAT3 WT) in both HeLa cells (Fig. 1 e) and 
Clone 9 cells (not depicted). Cells stably expressing the ER- 
localized LPAAT6 (a known LPAAT) (Chen et al., 2008) were 
used as a positive control for LPAAT activity. Furthermore, the 
acyltransferase activity was not observed when acidic and basic 
residues in the two conserved regions of the acyltransferase   
motif (Fig. 1 a) were changed to alanines in the LPAAT3 mutant 
(MT) (Fig. 1 e). Despite these changes, the catalytically inactive 
LPAAT3 MT was still partially localized to the Golgi complex 
(Fig.  S1  d).  Finally,  subcellular  fractions  enriched  in  Golgi 
membranes from cells stably expressing LPAAT3 also exhib-
ited an increase in LPAAT activity when endogenous LPA was 
used as an acceptor (Fig. 1 e). Together, these data show that 
LPAAT3 has LPA acyltransferase activity and that this activity 
Figure 1.  LPAAT3 motifs, subcellular localization, and activity. (a) LPAAT3 
contains two regions in a conserved PLsC acyltransferase motif and mul­
tiple predicted transmembrane domains. Mutations made in the two con­
sensus sequences are shown in bold (changing the residues to alanines). 
(b) The cis­Golgi marker 10E6 and rabbit anti­LPAAT3 colocalize. Bar =   
20 µm. (c) LPAAT3­DsRed colocalizes with the medial Golgi marker 
GPP130. Bar = 20 µm. (d) Post­nuclear supernatants from HeLa cells trans­
fected with LPAAT3 and LPAAT6 have elevated levels of LPA acyltransferase 
activity compared with control lysates. Lysophosphatidylcholine (LPC), lyso­
phosphatidylethanolamine  (LPE),  and  lysophosphatidylserine  (LPS)  were 
not significant acceptors of 
14C­palmitoyl­CoA in these cells. (e) Golgi from 
cells transiently (WT) or stably (ST) transfected with wild­type LPAAT3 have 
elevated LPAAT activity, whereas those with LPAAT3 containing mutations 
in residues required for catalytic activity do not (LPAAT3 MT). Isolated 
Golgi membranes from cells overexpressing wild­type LPAAT3 also exhibit 
elevated LPAAT when using endogenous LPA as a substrate (LPAAT3 WT 
Endog). Error bars are SD for three independent experiments.213 LPAAT3 REGULATES GOLGI STRUCTURE AND FUNCTION • Schmidt and Brown
microscopy (EM) revealed that knockdown cells had multiple 
Golgi stacks throughout the cytoplasm (Fig. 2 f). The combined 
fluorescence and EM studies show that knockdown of LPAAT3 
results in the formation of Golgi mini-stacks, which did not co-
localize with the ER protein PDI, or the ER exit site marker 
Sec24 (unpublished data).
LPAAT3 regulates the rate of Golgi tubule 
formation and retrograde trafficking in vivo
Pharmacological studies have suggested that Golgi membrane 
tubules are positively influenced by PLA2 activity and negatively 
influenced by LPAT activity (Brown et al., 2003). Cells were   
all treated with the fungal metabolite brefeldin A (BFA), which 
LPAAT3 mediates Golgi structure
Cells stably expressing LPAAT3-GFP were used to examine 
Golgi morphology in siRNA knockdown experiments. Knock-
down was verified by Western blot, which showed an average of 
85% reduction in LPAAT3 expression (Fig. 2, a and b). In 
LPAAT3 knockdown cells, the Golgi complex was fragmented, 
forming numerous juxta-nuclear puncta (Fig. 2 c). Quantification 
showed that 90% of LPAAT3 knockdown cells had fragmented 
Golgi ribbons (Fig. 2 d). Each of the fragments colocalized with 
cis-Golgi markers (10E6), medial-Golgi markers (mannosidase 
II), and TGN markers (M6PR) (Fig. 2 e). Golgi fragmentation 
caused by LPAAT3 knockdown was reversed by transfection 
with an siRNA-resistant LPAAT3 construct (Fig. 2 d). Electron 
Figure 2.  The Golgi fragments in LPAAT3 knockdown cells. (a) Cells stably overexpressing LPAAT3­GFP were transfected with a mixture of four siRNA 
molecules targeting LPAAT3 mRNA and analyzed by Western blot of cell lysates using anti­GFP and mannosidase II antibodies. (b) LPAAT3 expression 
was reduced by 85% (n = 3). (c) Immunofluorescence of GPP130 in LPAAT3 knockdown cells showed fragmented Golgi membranes. Bar = 20 µm.   
(d) The percentage of cells with fragmented Golgi ribbons as observed by immunofluorescence. (e) Golgi fragments contain markers for the cis­Golgi 
(10E6), the medial­Golgi (ManII) and the TGN (M6PR). Bar = 20 µm. (f) EM of thin sections from control, LPAAT3­GFP expressing, and knockdown cells. 
Higher magnification views of each boxed region are shown below. Bars = 500 nm.JCB • VOLUME 186 • NUMBER 2 • 2009   214
The inhibition of BFA-stimulated tubule formation by LPAAT3 
overexpression was not due to ineffective COPI disruption   
(Fig. S3 c). In contrast to overexpression, LPAAT3 knockdown 
cells exhibited a very rapid loss of the Golgi in BFA, so the   
experiment was repeated at 24°C to obtain quantitative data. The 
results showed that the half-time for loss of the Golgi in siRNA-
treated cells was 11 min compared with 25 min for overexpressing 
cells (17 min in control cells) (Fig. 3 c).
The LPAT inhibitor CI-976 also stimulates Golgi mem-
brane tubules (Drecktrah et al., 2003), presumably by increas-
ing the levels of positive curve-inducing LPLs. Thus, a prediction 
is  that  cells  overexpressing  or  knocked  down  for  LPAAT3 
should become, respectively, more resistant or sensitive to   
CI-976. Indeed, similar to BFA, cells overexpressing LPAAT3 
and treated with CI-976 formed tubules slower than controls, 
whereas tubule formation in LPAAT3 knockdown was much 
faster (Fig. 3, d and e). These results show that overexpressing 
LPAAT3  significantly  reduces  the  rate,  the  number,  and  the 
length of induced Golgi membrane tubules.
LPAAT3 overexpression inhibits Golgi 
tubule formation in vitro
Golgi membrane tubulation is attenuated in cells overexpress-
ing LPAAT3 in vivo, so we tested the effects of overexpression 
on Golgi tubulation using an in vitro reconstitution assay. In 
brief,  Golgi  complexes  from  tissue  culture  cells  stably  ex-
pressing LPAAT3-GFP were isolated, incubated with a frac-
tion  of  bovine  brain  cytosol  (BBC)  to  generate  membrane 
tubules,  and  analyzed  by  negative  stain  EM  (Cluett  et  al., 
1993; Banta et al., 1995). In reactions without BBC, no signif-
icant Golgi tubulation was observed regardless of the cells. 
With the addition of BBC, concentration-dependent tubulation 
was observed (Fig. 4 a); however, tubule formation was re-
duced 50% in Golgi membranes from cells overexpressing 
LPAAT3 compared with control (Fig. 4 b). Thus, increases in 
LPAAT3 significantly decrease Golgi membrane tubules both 
in vivo and in vitro.
LPAAT3 alters ERGIC-53 distribution
Overexpression of LPAAT3 dramatically decreases the rate of 
Golgi tubulation in vivo from BFA and CI-976 and in vitro from 
BBC, so we examined overexpression on the cellular localiza-
tion of an endogenous membrane marker involved in retrograde 
trafficking. The p58 receptor (hERGIC-53) is a lectin receptor 
that traffics between the cis-Golgi and the ER. When cells are 
incubated at 15°C, the p58 receptor accumulates in the cis-
Golgi and ERGIC compartments. When the cells are shifted 
from 15 to 37°C, p58 returns to the ER via membrane tubules 
(Saraste and Svensson, 1991; Klumperman et al., 1998). In con-
trol cells following the shift to 37°C, most the p58 receptor   
returned from the cis-Golgi to the ER in 5 min, whereas the 
LPAAT3-overexpressing cells showed a delay in the loss of 
Golgi and gain in ER localization of p58 (Fig. 4, c–e). Con-
versely, cells knocked down for LPAAT3 exhibited faster retro-
grade movement of p58 (Fig. 4, c and d). This shows that 
LPAAT3 also affects the retrograde recycling of endogenous 
p58 from the cis-Golgi to the ER.
generates numerous membrane tubules that redistribute Golgi 
membranes to the ER (Lippincott-Schwartz et al., 1989). Cells 
overexpressing LPAAT3 form Golgi tubules much slower than 
control and LPAAT3 MT cells (Fig. 3, a and b). Moreover, the 
Golgi tubules that did form in LPAAT3 WT overexpressing cells 
were far fewer in number and shorter in length than untransfected 
cells, as shown by Sholl analyses (Fig. S3, a and b; Sholl, 1953). 
Figure 3.  LPAAT3 overexpression slows BFA and CI-976–stimulated Golgi 
retrograde trafficking to the ER. (a) HeLa cells and cells transfected with 
LPAAT3 WT or LPAAT3 MT were treated with 10 µg/ml BFA and analyzed 
by immunofluorescence with GPP130 as a Golgi marker. Control cells, 
LPAAT3 MT cells, and LPAAT6 cells formed Golgi membrane tubules from 
2 to 5 min after addition of BFA and were completely relocalized to ER 
membranes within 10 min, whereas LPAAT3 WT cells were slower. Bar = 
20 µm. (b) The t1/2 of Golgi loss due to BFA tubulation was 5.5, 5.0, and 
4.0 min for HeLa cells, LPAAT3 MT cells, and LPAAT6 cells, respectively, 
and 11 min for LPAAT3 WT cells. (c) To measure LPAAT3 knockdown cells 
treated with BFA, the experiment above was repeated at 24°C where the   
t1/2 values for cells was 18 min for control cells, 25 min for cells over­
expressing LPAAT3 WT, and 11.2 min for LPAAT3 knockdown cells. Data are 
representative of three independent experiments. (d) Control cells, LPAAT3 
WT cells, LPAAT3 MT cells, and LPAAT3 siRNA knockdown cells were 
treated with 50 µM of the LPAT inhibitor CI­976 for 30 min. Cells express­
ing LPAAT3 WT were slower at forming Golgi membrane tubules, whereas 
knockdown cells were considerably faster. Bar = 20 µm. (e) Quantification 
of the CI­976 results. All error bars are SD for three independent experi­
ments (n = 300).215 LPAAT3 REGULATES GOLGI STRUCTURE AND FUNCTION • Schmidt and Brown
shown that altering the LPL and PL species in membranes 
can  alter  membrane  tubule  formation  and  Golgi  structure   
(de Figueiredo et al., 2000; Drecktrah et al., 2003; Chambers and 
Brown, 2004), and here we show that overexpression of LPAAT3 
significantly slows the formation of Golgi membrane tubules 
both in vivo and in vitro. These data agree with previous obser-
vations that PLA2 activity, which increases LPLs, is needed for 
membrane tubules to form (de Figueiredo et al., 2000). When 
LPAAT3  levels  were  reduced  using  siRNA  transfection,  the 
Golgi became hyper-sensitive to CI-976 and BFA and rapidly 
formed Golgi-to-ER retrograde membrane tubules, possibly 
due to an increase in LPA.
Membrane tubules also readily form at the TGN for the 
transport  of  cargo  to  the  plasma  membrane  and  endosomes 
(Bard and Malhotra, 2006; De Matteis and Luini, 2008), and 
LPAAT3 similarly affects trafficking kinetics in the TGN. Over-
expression of LPAAT3 slowed export of ts045 VSV-G from the 
TGN and secretion of ssHRP. Conversely, LPAAT3 knockdown 
accelerated secretion of ssHRP, but curiously not ts045 VSV-G. 
It is not clear why ssHRP and not ts045 VSV-G was accelerated. 
TGN cargoes exist by several independent pathways/carriers, 
and the differential effects of LPAAT3 knockdown on export of 
VSV-G and secretion of ssHRP may reflect different phospho-
lipid requirements for these carriers. Secretion may also be 
compromised indirectly through effects on retrograde traffick-
ing, which were also influenced by LPAAT3 levels.
Results here and elsewhere suggest that LPL/PL has a 
critical role in generating membrane curvature, which is re-
quired for the formation of membrane tubules and vesicles, the 
latter either from flattened cisternal membranes or from tubular 
LPAAT3 mediates anterograde trafficking
Golgi tubules have been documented to play an important role in 
anterograde membrane trafficking, particularly from the TGN 
(Bard and Malhotra, 2006), and perhaps in anterograde inter- 
cisternal movement under certain conditions (Trucco et al., 2004). 
Cells transfected with LPAAT3 or siRNA for LPAAT3 were   
cotransfected with ts045 VSV-G-DsRed to examine trafficking 
through the secretory pathway. At 40°C VSV-G-DsRed was lo-
cated in the ER as expected, and within 20–30 min after shift to 
32°C, it was transported to the Golgi complex (Fig. 5 a), with no 
significant difference between control and modified cells (un-
published data). However, we observed that in cells either over-
expressing  or  siRNA  treated  for  LPAAT3, VSV-G-DsRed 
remained in the Golgi longer and did not reach the plasma mem-
brane until 40–50 min after temperature shift (Fig. 5, a and b).
To examine anterograde trafficking of soluble cargo, cells 
were cotransfected with soluble secreted horseradish peroxi-
dase (ssHRP) (Bard et al., 2006), and HRP activity was mea-
sured in the media. The results showed that secretion of ssHRP 
was inhibited in cells overexpressing LPAAT3, but increased in 
LPAAT3  knockdown  cells  by  twofold  when  compared  with 
mock-transfected cells (Fig. 5 c). When LPAAT3 knockdown 
cells  were  rescued  using  the  LPAAT3  reversion  construct 
(LPAAT3 Rev), ssHRP secretion was similar to cells over-
expressing LPAAT3 WT.
Conclusions
We  have  identified  a  transmembrane  LPA  acyltransferase, 
LPAAT3, which localizes to the Golgi and ER, and consumes 
LPA  to  produce  PA.  Previous  pharmacological  studies  have 
Figure 4.  In vitro tubulation of Golgi mem-
branes and ERGIC-53 trafficking. (a) Isolated 
Golgi membranes from control cells and cells 
stably expressing LPAAT3 WT were incubated 
with bovine brain cytosol (BBC) to form mem­
brane tubules. Bars = 500 nm. (b) In the LPAAT3 
cells, the percentage of tubulated membranes 
was only 20% compared with 60% of con­
trol Golgi membranes. (c) Control Clone 9 rat 
hepatocytes, Clone 9 cells stably expressing 
LPAAT3­GFP, and Clone 9 cells knocked down 
for LPAAT3 were incubated at 15°C for 3 h, 
then shifted to 37°C and fixed after 0, 2, 5, 
7, and 10 min and visualized for endogenous 
p58 (ERGIC­53). Bar = 20 µm. (d) Quantifica­
tion of cells with Golgi­localized p58 after   
2 min at 37°C. (e) Quantification of cells with 
Golgi­localized p58 after 5 min at 37°C. Cells 
overexpressing  LPAAT3­GFP  retained  p58  in 
the  Golgi,  whereas  cells  knocked  down  for 
LPAAT3 transported p58 to the ER more rap­
idly than control cells. Error bars are SD for 
three independent experiments n = 300.JCB • VOLUME 186 • NUMBER 2 • 2009   216
is also required for forming post-TGN trafficking intermediates 
(Maeda et al., 2001; Baron and Malhotra, 2002). DAG is also 
associated with multiple trafficking events from the Golgi   
(Fernandez-Ulibarri et al., 2007; Asp et al., 2009).
In addition to changes in membrane trafficking, reduced 
expression of LPAAT3 caused the Golgi ribbon to fragment into 
mini-stacks. The results suggest that by altering the LPL/PL 
ratio in Golgi membranes, changes in either positive or negative 
curve can alter the stability of the compact cisternal morphology. 
Of course, any significant change in the LPL/PL ratio could have 
multiple direct and indirect effects.
Aside from phosphoinositides, the roles of specific PLs in 
membrane trafficking are still elusive because multiple pathways 
exist for the metabolism of PLs. PL levels are regulated by cel-
lular needs for de novo PL synthesis via the Kennedy pathway 
but  also  by  downstream  organelle  trafficking  events  (Gaspar   
et al., 2008). Membrane lipids such as LPLs and DAG may also 
be short-lived and localized to specific domains where cargo is 
concentrated for tubule or vesicle formation. In addition, it is   
becoming increasingly clear that continual PL remodeling via 
Lands’ cycle enzymes such as LPAAT3 and PLA2 plays impor-
tant roles in the formation of membrane trafficking intermedi-
ates and in the maintenance of the Golgi complex.
Materials and methods
Materials
Antibodies against the following antigens were used: GPP130 (Adam 
Linstead, Carnegie Mellon University), hManII (Kelly Moreman, University of 
Georgia), 10E6 (Wood et al., 1991), M6PR (Brown and Farquhar, 1987), 
COP (ABR), p58 (Jaakko Saraste, Bergen University), and FITC/TRITC 
conjugated secondary antibodies (Jackson ImmunoResearch Laboratories). 
Peptide antibody against LPAAT3 was designed and generated by Pacific 
Immunology. All phospholipids were from Avanti Polar Lipids, chromatog­
raphy  reagents  were  from  Alltech  Chromatography  and  radiolabeled   
Palmitoyl­CoA [palmitoyl­1­
14C] was from PerkinElmer Life Sciences.
DNA constructs and transfection
LPAAT3 (AGPAT3) cDNA was obtained in pCMV­SPORT6 from the IMAGE 
Human library (Invitrogen). Using PCR and the multiple cloning site of 
pEGFP N­1 (Clontech Laboratories, Inc.) or pDsRed N­1, LPAAT3 was in­
serted with EGFP or DsRed at the C terminus. To make the catalytic mutant 
of LPAAT3, Quick ChangeII (Stratagene) was used. For secretion measure­
ments, the pEGFP N­1 SS­HRP­Flag plasmid was from Vivek Malhotra. To 
generate ts045 VSV­G­DsRed, the VSV­G sequence was ligated into the 
vector from pEGFP N­1 ts045 VSV­G, which was from Brian Storrie (Uni­
versity of Arkansas). All constructs were verified by DNA sequencing.
For PCR cloning of LPAAT3, the following forward and reverse primers   
were used: GCAATTATCTCGAGCATGGGCCTGCTGGGC and CGG­
CGGTACCGTTTCCTTTTTCTTAAACTCTTGGTTTCCGTAGCTGGA which 
contain XHOI and KPNI restriction digest sites. A mixture of four siRNA 
duplexes  designed  from  the  human  AGPAT3  cDNA  sequence  (SMART­
pool; Dharmacon) was transfected into cells stably expressing LPAAT3­GFP   
using lipofectamine RNAi MAX (Invitrogen) for 72 h. The following siRNA 
sequences were transfected with their antisense compliments: GAGAC­
CAAGCACCGCGUUAUU,  CGUCUUUGCCAGCGGAUCAUU,  GCUC­
CAAGGUCCUGCUAAUU, and GGAAAUAGAAUGACGGGAAUU.
DNA constructs were transfected using Fugene (Roche) and pro­
cessed for immunofluorescence experiments within 24–48 h unless other­
wise indicated. For cells transfected with ts045 VSV­G­DsRed, cells were 
transfected and grown at 40°C for 18 h before temperature shift.
Tissue culture and immunofluorescence
HeLa cells and Clone 9 rat hepatocytes were grown and maintained at 
37°C, 100% humidity, and 5% CO2. Cells stably­expressing LPAAT3­GFP 
were selected with 500 µg/ml G418 (Mediatech).
precursors. In addition, however, PA is thought to have impor-
tant roles in CtBP3/BARS50-mediated vesicle fission and/or 
fusion by generating negative membrane curvature and forming 
microdomains for protein docking (Kooijman et al., 2003; Yang 
et al., 2008). Moreover PLD, which also generates PA, is impor-
tant for establishing transport carriers at the TGN (Bard and 
Malhotra, 2006; Yang et al., 2008). DAG may be an indirect 
product of LPAAT3 as increased PA levels may drive DAG lev-
els via PA phosphatase. Importantly, PKD, which binds to DAG, 
Figure 5.  LPAAT3 and TGN trafficking. (a) Cells overexpressing LPAAT3 
or knocked down for LPAAT3 were transfected with ts045 VSV­G­DsRed 
and incubated at 40°C for 18 h, then released to 32°C for various time 
points. Bar = 20 µm. (b) The amount of ts045 VSV­G­DsRed fluorescence in 
the Golgi complex was subtracted from the total fluorescence to determine 
the amount of post­Golgi transport of ts045 VSV­G. Error bars represent 
SD for three independent experiments (n = 100). (c) Cells were transfected 
with a secretable form of horseradish peroxidase (ssHRP). Media and   
lysates were tested every 2 h for HRP activity. Error bars represent three 
independent experiments.217 LPAAT3 REGULATES GOLGI STRUCTURE AND FUNCTION • Schmidt and Brown
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